Globe And Mail Examines RTS,S Malaria Vaccine Trials In Kenyan Town
Main Category: Tropical DiseasesAlso Included In: Immune System / Vaccines
Article Date: 18 Jun 2009 - 7:00 PDT
| Patient / Public: | ![]() | |
| Healthcare Prof: | ![]() |
The Globe and Mail examines GlaxoSmithKline's RTS,S malaria vaccine trials in Kilifi, Kenya - one of the sites where the experimental vaccine is being tested. "The stories of the mothers of Kilifi open a window on the challenges faced by researchers as they build a trial that will include more than 16,000 babies from 11 sites spread across sub-Saharan Africa," the Globe and Mail reports.
The first five babies taking part in the trial, which has also received funds from the Bill & Melinda Gates Foundation, were vaccinated in Tanzania in late May. Now researchers and medical professionals are "readying millions of dollars worth of new laboratory equipment, training field workers and canvassing mothers in rural villages in Burkina Faso, Gabon and Ghana in the west, Mozambique and Malawi in the south and Kenya and Tanzania in the north to sign up the final volunteers," according to the Globe and Mail.
Patricia Njuguna, a pediatrician who is a "principle investigator on the crucial phase-three trials," first came to Kilifi as a medical officer. Last year, Njuguna and colleagues worked with "dozens of field workers and clinicians on a smaller trial of the same vaccine" that broke "new ground," and showed that "rates of malaria among babies and toddlers who received the vaccine were 53 percent lower than those of children who did not," the newspaper writes. However, spreading "enthusiasm" about the vaccine trials to "poor villages buried at the rough ends of old roads, where medical care is rare and deadly illnesses abundant, is no small feat," writes the Mail and Guardian.
According to the article, suspicion and skepticism are some of the major obstacles in recruitment. But the newspaper reports that the "meticulous explanations and consent required to bring malaria trials to an international standard seems to be winning the trust of Kilifi's people, if not always the understanding" (Alsop, Mail and Guardian, 6/16).
This information was reprinted from globalhealth.kff.org with kind permission from the Henry J. Kaiser Family Foundation. You can view the entire Kaiser Daily Global Health Policy Report, search the archives and sign up for email delivery at globalhealth.kff.org.
© Henry J. Kaiser Family Foundation. All rights reserved.
Visit our tropical diseases section for the latest news on this subject.
MLA
15 Feb. 2012. <http://www.medicalnewstoday.com/releases/154457.php>
APA
http://www.medicalnewstoday.com/releases/154457.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.



